JBF Capital’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-363,531
Closed -$141K 95
2020
Q1
$141K Buy
+363,531
New +$132K 0.03% 53

JBF Capital's CORV Position: Q2 2020 in Review

JBF Capital sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 363,531 shares — an estimated $141K sold.

JBF Capital first reported a position in CORV in Q1 2020 and held it in 1 quarter. The position peaked at $141K in Q1 2020. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

  • JBF Capital reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
  • JBF Capital sold 363,531 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $141K.
  • JBF Capital first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2020 and held it in 1 quarter.
  • JBF Capital's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $141K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on JBF Capital's 13F filing for Q2 2020, filed 5 Aug 2020.